Rapid and sustained improvement in Itch in children aged 6–11 years with severe atopic dermatitis treated with dupilumab: Analysis from the LIBERTY AD PEDS phase 3 trial

Amy S. Paller; Stephen Weidinger; Gil Yosipovitch; Jonathan I. Silverberg; Jashin J. Wu; Mike Bastian; Zhen Chen; Randy Prescilla; Ana B. Rossi; Dimittri Delevry

doi:10.13140/rg.2.2.20959.79528

Conference proceeding

Rapid and sustained improvement in Itch in children aged 6–11 years with severe atopic dermatitis treated with dupilumab: Analysis from the LIBERTY AD PEDS phase 3 trial

Amy S. Paller, Stephen Weidinger, Gil Yosipovitch, Jonathan I. Silverberg, Jashin J. Wu, Mike Bastian, Zhen Chen, Randy Prescilla, Ana B. Rossi and Dimittri Delevry

2021-01-01

DOI: https://doi.org/10.13140/rg.2.2.20959.79528

Metrics

6 Record Views

Details

Title: Rapid and sustained improvement in Itch in children aged 6–11 years with severe atopic dermatitis treated with dupilumab: Analysis from the LIBERTY AD PEDS phase 3 trial
Creators: Amy S. Paller
Stephen Weidinger
Gil Yosipovitch
Jonathan I. Silverberg
Jashin J. Wu
Mike Bastian
Zhen Chen
Randy Prescilla
Ana B. Rossi
Dimittri Delevry
Publisher: Unpublished
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Conference proceeding
Record Identifier: 991031970790402976